We are live on ! Find out more
GWM

Geneos Wealth Management Portfolio holdings

AUM $4.9B
1-Year Est. Return 23.65%
This Fund
S&P 500
This Quarter Est. Return
+6.34%
1 Year Est. Return
+23.65%
3 Year Est. Return
+66.72%
5 Year Est. Return
+71.27%
10 Year Est. Return
+298.51%
AUM
$2.62B
AUM Growth
+$368M
Cap. Flow
+$229M
Cap. Flow %
8.75%
Top 10 Hldgs %
18.1%
Holding
2,638
New
585
Increased
1,008
Reduced
426
Closed
81

Sector Composition

Rank Sector Weight
1 Technology 8.21%
2 Financials 4.98%
3 Healthcare 4.3%
4 Consumer Discretionary 3.17%
5 Industrials 3.08%

Similar funds

Geneos Wealth Management's Q3 2024 Portfolio in Review

As of Q3 2024, Geneos Wealth Management held 2,638 positions worth $2.62B, up 16% from $2.25B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Geneos Wealth Management deployed $229M of net new capital in Q3 2024, opening 585 new positions and adding to 1,008 existing holdings. Its largest new stake was iShares Core MSCI International Developed Markets ETF: 104,319 shares worth $7.39M.

By sector, the portfolio is most concentrated in Technology at 8.2% of assets, down from 8.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $11.9M trimmed.

  • Geneos Wealth Management's largest Q3 2024 buy was iShares Core MSCI International Developed Markets ETF: 104,319 shares worth $7.39M.
  • Geneos Wealth Management added most to PGIM Ultra Short Bond ETF in Q3 2024, an estimated $9.4M increase.
  • Geneos Wealth Management's biggest Q3 2024 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $11.9M.
  • Geneos Wealth Management fully exited iShares MSCI Germany ETF in Q3 2024, selling an estimated $2.37M.
  • Geneos Wealth Management's ten largest holdings make up 18% of its $2.62B portfolio in Q3 2024.
  • Geneos Wealth Management opened 585 new positions and closed 81 in Q3 2024.
  • Geneos Wealth Management's portfolio value rose 16% quarter-over-quarter to $2.62B.

Based on Geneos Wealth Management's 13F filing for Q3 2024, filed 14 Nov 2024.